• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

华法林与布可隆联合治疗对心房颤动患者抗凝的影响。

Effects of combination therapy with warfarin and bucolome for anticoagulation in patients with atrial fibrillation.

机构信息

Division of Cardiology, Niigata University School of Medical and Dental Sciences, Niigata, Japan.

出版信息

Circ J. 2011;75(1):201-3. doi: 10.1253/circj.cj-10-0842. Epub 2010 Dec 2.

DOI:10.1253/circj.cj-10-0842
PMID:21139249
Abstract

BACKGROUND

Bucolome, a nonsteroidal antiinflammatory drug, enhances the effects of warfarin. In the present study, the effects of combination therapy (bucolome+warfarin) vs. warfarin alone on atrial fibrillation were investigated.

METHODS AND RESULTS

Combined therapy resulted in a decrease in the warfarin dose to approximately one-third. The fluctuations of the international normalized ratio and the time in therapeutic range were similar in both groups. There was no adverse effect in either group. Interestingly, uric acid was lower in the bucolome group.

CONCLUSIONS

Bucolome enhanced the effects of warfarin, resulting in a decreased dose of warfarin without adverse effects and it showed similar anticoagulant stability to warfarin alone.

摘要

背景

布可隆(一种非甾体类抗炎药)可增强华法林的效果。本研究旨在探讨布可隆联合华法林治疗与华法林单药治疗相比,对房颤的疗效。

方法与结果

联合治疗可使华法林剂量减少至约三分之一。两组的国际标准化比值波动和治疗范围内时间相似。两组均无不良反应。有趣的是,布可隆组的尿酸水平较低。

结论

布可隆增强了华法林的效果,使华法林的剂量降低而无不良反应,且抗凝稳定性与华法林单药治疗相似。

相似文献

1
Effects of combination therapy with warfarin and bucolome for anticoagulation in patients with atrial fibrillation.华法林与布可隆联合治疗对心房颤动患者抗凝的影响。
Circ J. 2011;75(1):201-3. doi: 10.1253/circj.cj-10-0842. Epub 2010 Dec 2.
2
Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.日本非瓣膜性心房颤动患者在接受华法林预防卒中时抗凝管理未达最佳状态。
J Stroke Cerebrovasc Dis. 2017 Oct;26(10):2102-2110. doi: 10.1016/j.jstrokecerebrovasdis.2017.04.030. Epub 2017 May 19.
3
Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.非瓣膜性心房颤动患者缺血性卒中的病因
Cerebrovasc Dis. 2016;42(3-4):196-204. doi: 10.1159/000445723. Epub 2016 Apr 26.
4
Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).非瓣膜性心房颤动患者停用利伐沙班与华法林的结局:ROCKET AF 试验(利伐沙班每日 1 次口服、直接 Xa 因子抑制剂与维生素 K 拮抗剂预防心房颤动卒中及栓塞的随机临床试验)分析。
J Am Coll Cardiol. 2013 Feb 12;61(6):651-8. doi: 10.1016/j.jacc.2012.09.057.
5
The stereoselective effects of bucolome on the pharmacokinetics and pharmacodynamics of racemic warfarin.布可隆对消旋华法林药代动力学和药效学的立体选择性作用。
J Clin Pharmacol. 2001 Apr;41(4):459-64. doi: 10.1177/00912700122010186.
6
Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.非瓣膜性心房颤动患者的长期凝血酶原时间国际标准化比值(PT-INR)水平与临床事件:特别提及低强度华法林治疗
J Cardiol. 2014 Aug;64(2):127-32. doi: 10.1016/j.jjcc.2013.11.015. Epub 2014 Jan 17.
7
Design and rationale for the WARFA trial: a randomized controlled cross-over trial testing the therapeutic equivalence of branded and generic warfarin in atrial fibrillation patients in Brazil.WARFA试验的设计与原理:一项随机对照交叉试验,旨在测试巴西房颤患者中品牌华法林与通用型华法林的治疗等效性。
BMC Cardiovasc Disord. 2017 Jun 7;17(1):148. doi: 10.1186/s12872-017-0584-4.
8
Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: perspectives from the observational, prospective WATER Registry.评估华法林在治疗范围内的时间对土耳其心房颤动患者结局的影响:来自观察性前瞻性WATER注册研究的观点
Cardiol J. 2015;22(5):567-75. doi: 10.5603/CJ.a2015.0035. Epub 2015 Jun 23.
9
D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin.足量华法林治疗的缺血性中风患者中D-二聚体与凝血酶原时间国际标准化比值的比较
J Stroke Cerebrovasc Dis. 2016 Jul;25(7):1781-1785. doi: 10.1016/j.jstrokecerebrovasdis.2016.03.037. Epub 2016 Apr 18.
10
The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.塔斯马尼亚心房颤动研究:2011 - 2015年向直接口服抗凝剂的转变
Cardiovasc Ther. 2017 Jun;35(3). doi: 10.1111/1755-5922.12254.

引用本文的文献

1
Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review.心房颤动和静脉血栓栓塞研究中报告的维生素K拮抗剂控制措施:一项系统评价。
BMJ Open. 2014 Jun 20;4(6):e005379. doi: 10.1136/bmjopen-2014-005379.